Abstract
Prior to the widespread adoption of intracoronary stent implantation, potential complications of percutaneous coronary intervention (PCI) necessitated the presence of backup cardiac surgery. However, as stent implantation has become the predominant form of PCI, the incidence of emergent cardiac surgery has declined exponentially. Despite this, current guidelines recommend against the performance of elective PCI at hospitals without on-site cardiac surgery and recommend that primary PCI for ST-segment elevation myocardial infarction (STEMI) might be considered at hospitals without backup cardiac surgery. These recommendations are based predominantly on two principles: (1) hospital volume for PCI is strongly associated with clinical outcomes, and (2) results from a large registry study, in which the authors reported a substantial increase in mortality among patients undergoing non-primary/rescue PCI at hospitals without backup cardiac surgery. Since that time, evidence from multiple studies has suggested that performance of PCI at hospitals without backup cardiac surgery is feasible, safe, and both clinically and cost effective. Among STEMI patients, in particular, performance of primary PCI at hospitals without on-site cardiac surgery reduces time to reperfusion and subsequent adverse cardiovascular events as well as likely reducing infarct size. In this review, we will examine the evidence surrounding the performance of PCI for stable and unstable coronary disease at hospitals without on-site backup cardiac surgery.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Smith Jr SC, Feldman TE, Hirshfeld Jr JW, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113(7):e166–286.
Stone GW, Brodie BR, Griffin JJ, et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol. 1998;31(1):23–30.
The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. New Engl J Med. 1997;336(24):1689–96.
Jaber WA, Lennon RJ, Mathew V, et al. Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator. J Am Coll Cardiol. 2005;46(8):1473–8.
Shubrooks Jr SJ, Nesto RW, Leeman D, et al. Urgent coronary bypass surgery for failed percutaneous coronary intervention in the stent era: is backup still necessary? Am Heart J. 2001;142(1):190–6.
Singh M, Rihal CS, Gersh BJ, et al. Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience. Circulation. 2007;115(22):2835–41.
Yang EH, Gumina RJ, Lennon RJ, et al. Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003. J Am Coll Cardiol. 2005;46(11):2004–9.
Altmann DB, Racz M, Battleman DS, et al. Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2,242 patients. Am Heart J. 1996;132(3):503–7.
Haan CK, O’Brien S, Edwards FH, et al. Trends in emergency coronary artery bypass grafting after percutaneous coronary intervention, 1994–2003. Ann Thorac Surg. 2006;81(5):1658–65.
Talley JD, Weintraub WS, Roubin GS, et al. Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years. Circulation. 1990;82(4):1203–13.
Vogt A, Bonzel T, Harmjanz D, et al. PTCA registry of German community hospitals. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte (ALKK) Study Group. Eur Heart J. 1997;18(7):1110–4.
• Pride YB, Canto JG, Frederick PD, Gibson CM. Outcomes among patients with non-ST-segment elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery. JACC Cardiovasc Interv. 2009;2(10):944–52. Only study comparing outcomes exclusively among patients with NSTEMI presenting to hospitals with and without on-site cardiac surgery.
• Pride YB, Canto JG, Frederick PD, Gibson CM. Outcomes among patients with ST-segment-elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery. Circ Cardiovasc Qual Outcomes. 2009;2(6):574–82. Study of large MI registry evaluating outcomes of STEMI patients presenting to hospitals with and without backup cardiac surgery.
Smith Jr SC, Feldman TE, Hirshfeld Jr JW, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113(1):156–75.
Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110(9):e82–e292.
• Kumbhani DJ, Cannon CP, Fonarow GC, et al. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA. 2009;302(20):2207–13. Large registry evaluating outcomes among STEMI patients presenting to hospitals with high and low volume of PCI.
Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. New Engl J Med. 2000;342(21):1573–80.
Magid DJ, Calonge BN, Rumsfeld JS, et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA. 2000;284(24):3131–8.
Srinivas VS, Hailpern SM, Koss E, et al. Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. J Am Coll Cardiol. 2009;53(7):574–9.
McGrath PD, Wennberg DE, Dickens Jr JD, et al. Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent. JAMA. 2000;284(24):3139–44.
Wennberg DE, Lucas FL, Siewers AE, et al. Outcomes of percutaneous coronary interventions performed at centers without and with onsite coronary artery bypass graft surgery. JAMA. 2004;292(16):1961–8.
Gruentzig AR. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1:1.
Gruentzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. New Engl J Med. 1979;301:8.
Sinclair IN, McCabe CH, Sipperly ME, Baim DS. Predictors, therapeutic options and long-term outcome of abrupt reclosure. Am J Cardiol. 1988;61(14):61G–6G.
de Feyter PJ, van den Brand M, Laarman GJ, et al. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up. Circulation. 1991;83(3):927–36.
Hannan EL, Arani DT, Johnson LW, et al. Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes. JAMA. 1992;268(21):3092–7.
Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. New Engl J Med. 1987;316(12):701–6.
Seshadri N, Whitlow PL, Acharya N, et al. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation. 2002;106(18):2346–50.
Ting HH, Garratt KN, Singh M, et al. Low-risk percutaneous coronary interventions without on-site cardiac surgery: 2 years’ observational experience and follow-up. Am Heart J. 2003;145(2):278–84.
Long KH, McMurtry EK, Lennon RJ, et al. Elective percutaneous coronary intervention without on-site cardiac surgery: clinical and economic implications. Med Care. 2006;44(5):406–13.
• Frutkin AD, Mehta SK, Patel T, et al. Outcomes of 1,090 consecutive, elective, nonselected percutaneous coronary interventions at a community hospital without onsite cardiac surgery. Am J Cardiol. 2008;101(1):53–7. Largest series of patients undergoing PCI at a community hospital.
Melberg T, Nordrehaug JE, Nilsen DW. A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: a randomized trial in nonemergent patients. Eur J Cardiovasc Prev Rehabil. 2010;17(2):235–43.
Melberg T, Nilsen DW, Larsen AI, et al. Nonemergent coronary angioplasty without on-site surgical backup: a randomized study evaluating outcomes in low-risk patients. Am Heart J. 2006;152(5):888–95.
Roussanov O, Estacio G, Capuno M, et al. Nonemergent percutaneous coronary interventions in a veterans affairs medical center without onsite cardiac surgery. Am Heart J. 2006;152(5):909–13.
The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994;89(4):1545–56.
Boden WE, O’Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. New Engl J Med. 1998;338(25):1785–92.
The FRISC II Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999;354(9180):708–15.
Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet. 2000;356(9223):9–16.
Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet. 2002;360(9335):743–51.
Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. New Engl J Med. 2009;360(21):2165–75.
Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278(23):2093–8.
Nordmann AJ, Bucher H, Hengstler P, et al. Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction. Cochrane Database Syst Rev. 2005;18(2):CD 005313.
Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 2002;287(15):1943–51.
Wharton Jr TP, McNamara NS, Fedele FA, et al. Primary angioplasty for the treatment of acute myocardial infarction: experience at two community hospitals without cardiac surgery. J Am Coll Cardiol. 1999;33(5):1257–65.
Singh M, Ting HH, Gersh BJ, et al. Percutaneous coronary intervention for ST-segment and non-ST-segment elevation myocardial infarction at hospitals with and without on-site cardiac surgical capability. Mayo Clin Proc. 2004;79(6):738–44.
Weaver WD, Litwin PE, Martin JS. Use of direct angioplasty for treatment of patients with acute myocardial infarction in hospitals with and without on-site cardiac surgery. The Myocardial Infarction, Triage, and Intervention Project Investigators. Circulation. 1993;88(5 Pt 1):2067–75.
Brush Jr JE, Thompson S, Ciuffo AA, et al. Retrospective comparison of a strategy of primary coronary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction in a community hospital without cardiac surgical backup. J Invasive Cardiol. 1996;8(2):91–8.
Wharton Jr TP, Grines LL, Turco MA, et al. Primary angioplasty in acute myocardial infarction at hospitals with no surgery on-site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplasty. J Am Coll Cardiol. 2004;43(11):1943–50.
Shiraishi J, Kohno Y, Sawada T, et al. In-hospital outcomes of primary percutaneous coronary interventions performed at hospitals with and without on-site coronary artery bypass graft surgery. Circ J. 2007;71(8):1208–12.
• Hannan EL, Zhong Y, Racz M, et al. Outcomes for patients with ST-elevation myocardial infarction in hospitals with and without onsite coronary artery bypass graft surgery: the New York State experience. Circ Cardiovasc Interv. 2009;2(6):519–27. Large state registry evaluating STEMI patients undergoing primary PCI at hospitals with and without on-site cardiac surgery.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pride, Y.B., Gibson, C.M. Percutaneous Coronary Interventions in Facilities Without Cardiac Surgery on Site. Curr Cardiol Rep 13, 432–438 (2011). https://doi.org/10.1007/s11886-011-0197-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11886-011-0197-y